当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析 - 现金流量表

智飞生物

(300122)

  

流通市值:172.69亿  总市值:292.28亿
流通股本:14.14亿   总股本:23.94亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,053,435,486.3214,680,558,384.8310,955,411,456.37,507,829,380.15
  收到的税费返还1,546,975.24406,133.03406,133.03-
  收到其他与经营活动有关的现金103,102,357.04348,560,940.09169,973,323.0740,814,335.27
  经营活动现金流入小计2,158,084,818.615,029,525,457.9511,125,790,912.47,548,643,715.42
  购买商品、接受劳务支付的现金930,076,569.085,467,257,130.064,475,776,499.63,866,010,465.3
  支付给职工以及为职工支付的现金538,908,087.641,785,937,410.711,358,618,838.08913,928,832.59
  支付的各项税费103,402,756.77444,345,468.94339,675,547.02249,300,999.73
  支付其他与经营活动有关的现金307,628,110.32,164,665,764.551,966,701,133.13955,028,729.31
  经营活动现金流出小计1,880,015,523.799,862,205,774.268,140,772,017.835,984,269,026.93
  经营活动产生的现金流量净额278,069,294.815,167,319,683.692,985,018,894.571,564,374,688.49
二、投资活动产生的现金流量:
  收回投资收到的现金-5,650,0004,000,0004,000,000
  处置固定资产、无形资产和其他长期资产收回的现金净额20,0006,941,779.96,835,079.96,817,645.6
  收到的其他与投资活动有关的现金-76,653,395.9276,938,380.01-
  投资活动现金流入小计20,00089,245,175.8287,773,459.9110,817,645.6
  购建固定资产、无形资产和其他长期资产支付的现金102,111,213.21619,186,865.2462,338,343.65259,397,490.09
  支付其他与投资活动有关的现金-65,000,00065,000,000-
  投资活动现金流出小计102,111,213.21684,186,865.2527,338,343.65259,397,490.09
  投资活动产生的现金流量净额-102,091,213.21-594,941,689.38-439,564,883.74-248,579,844.49
三、筹资活动产生的现金流量:
  取得借款收到的现金7,985,500,00013,347,907,154.5612,997,907,154.567,721,175,247.56
  收到其他与筹资活动有关的现金217,1765,543,763.985,543,763.983,459,226.7
  筹资活动现金流入小计7,985,717,17613,353,450,918.5413,003,450,918.547,724,634,474.26
  偿还债务支付的现金8,937,782,848.4717,640,883,864.4115,472,699,926.419,015,838,545.51
  分配股利、利润或偿付利息支付的现金115,158,049.99344,806,186.96267,017,904.33146,234,362
  支付其他与筹资活动有关的现金8,026,977.82100,560,885.3618,030,152.7812,888,115.98
  筹资活动现金流出小计9,060,967,876.2818,086,250,936.7315,757,747,983.529,174,961,023.49
  筹资活动产生的现金流量净额-1,075,250,700.28-4,732,800,018.19-2,754,297,064.98-1,450,326,549.23
四、汇率变动对现金及现金等价物的影响-16,911,711.49-687,237.77-407,575.19-443,332.42
五、现金及现金等价物净增加额-916,184,330.17-161,109,261.65-209,250,629.34-134,975,037.65
  加:期初现金及现金等价物余额2,542,960,105.312,704,069,366.962,704,069,366.962,698,856,401.98
  期末现金及现金等价物余额1,626,775,775.142,542,960,105.312,494,818,737.622,563,881,364.33
补充资料:
  净利润--14,745,264,578.46--598,076,899.29
  资产减值准备-14,128,158,835.41-383,085,818.57
  固定资产和投资性房地产折旧-454,483,762.7-221,754,519.31
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-454,483,762.7-221,754,519.31
  无形资产摊销-47,638,923.69-22,464,701.99
  长期待摊费用摊销-19,171,476.87-8,447,401.05
  处置固定资产、无形资产和其他长期资产的损失--5,880,932.83--5,815,453.17
  固定资产报废损失-377,197.29-246,079.48
  公允价值变动损失-14,221,154.72--2,355,610.36
  财务费用-320,216,154.03-156,744,146.88
  投资损失--13,903.16--
  递延所得税--2,739,062,471.7--179,538,422.71
  其中:递延所得税资产减少--2,730,416,491.8--175,640,424.05
    递延所得税负债增加--8,645,979.9--3,897,998.66
  存货的减少-3,621,815,564.67-1,143,612,371.67
  经营性应收项目的减少-4,906,833,752.15-2,440,877,877.54
  经营性应付项目的增加--868,543,909.5--2,033,599,356.61
  现金的期末余额-2,542,960,105.31-2,563,881,364.33
  减:现金的期初余额-2,704,069,366.96-2,698,856,401.98
  现金及现金等价物的净增加额--161,109,261.65--134,975,037.65
公告日期2026-04-282026-04-282025-10-302025-08-19
审计意见(境内)标准无保留意见
TOP↑